OMNICELL, INC. — Director's Dealing 2020

Dec 8, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: OMNICELL, Inc (OMCL)
CIK: 0000926326
Period of Report: 2020-12-08

Reporting Person: LIPPS RANDALL A (Director, Chairman, President and CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-12-08	Common Stock	M	16849	—	Acquired	168965	Direct
2020-12-08	Common Stock	S	16849	$110.5354	Disposed	152116	Direct
2020-12-08	Common Stock	M	651	—	Acquired	152767	Direct
2020-12-08	Common Stock	S	651	$111.0714	Disposed	152116	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-12-08	Stock Options NQ (Right to Buy)	$34.02	M	17500	Disposed	2025-02-05	Common Stock (17500)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	152116	Direct
Common Stock	229113	Indirect
Common Stock	8303	Indirect

Footnotes

F1: Shares held in trust with Mr. Lipps' wife.

F2: Shares held in trust for the benefit of Mr. Lipps' children.

F3: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan adopted by the reporting person on February 20, 2020.

F4: The price reported in Column 4 is the average price of $110.5354. The sold price range between $110.00 to $110.99. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F5: The price reported in Column 4 is the average price of $111.0714. The sold price range between $111.01 to $111.11. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.